Novavax, Inc. (NASDAQ:NVAX) [Trend Analysis] stock closed at $6.41 (click here) in last session with the total traded volume of
26.28 Million. Novavax reports positive top-line data from its Phase 2
clinical trial of RSV F Vaccine, used to protect infants via maternal
immunization. The purpose of the Phase 2 trial was to evaluate the
safety and immunogenicity of the RSV F Vaccine in healthy pregnant
women.Women in the vaccinated group demonstrated a geometric mean
14-fold rise in anti-F IgG, 29-fold rise in PCA, and 2-fold rise in
microneutralization titers...
This stuff always makes me worry, regardless, of it's benevolence. I am not aware of a vaccine provided during pregnancy. This also isn't about every pregnant woman.
Test ID: FACT: F-Actin Ab, IgG, S
Evaluating patients suspected of having autoimmune hepatitis (click here)
Autoimmune hepatitis (AIH) is caused by chronic inflammation within the liver, resulting in damage to the hepatocytes.(1) Initially, patients with AIH may be clinically asymptomatic, usually identified only through an incidental finding of abnormal liver function tests. At a more advanced stage, patients may manifest with symptoms such as jaundice, pruritus, and/or ascites, which are secondary to the more extensive liver damage...
I am sure the Mayo Clinic could address any cutting edge pharmaceuticals.
This stuff always makes me worry, regardless, of it's benevolence. I am not aware of a vaccine provided during pregnancy. This also isn't about every pregnant woman.
Test ID: FACT: F-Actin Ab, IgG, S
Evaluating patients suspected of having autoimmune hepatitis (click here)
Autoimmune hepatitis (AIH) is caused by chronic inflammation within the liver, resulting in damage to the hepatocytes.(1) Initially, patients with AIH may be clinically asymptomatic, usually identified only through an incidental finding of abnormal liver function tests. At a more advanced stage, patients may manifest with symptoms such as jaundice, pruritus, and/or ascites, which are secondary to the more extensive liver damage...
I am sure the Mayo Clinic could address any cutting edge pharmaceuticals.
